Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 777,707 | 720,938 | 721,789 | 637,592 | 626,336 |
| Cost of Goods | 306,925 | 311,436 | 299,183 | 258,250 | 266,746 |
| Gross Profit | 470,782 | 409,502 | 422,606 | 379,342 | 359,590 |
| Operating Expenses | 224,085 | 224,843 | 250,933 | 186,344 | 216,011 |
| Operating Income | 247,622 | 185,095 | 171,856 | 193,248 | 144,325 |
| Interest Expense | 7,584 | 7,828 | 8,110 | 9,495 | 7,692 |
| Other Income | 52 | 169 | 208 | 69 | 140 |
| Pre-tax Income | 240,090 | 177,436 | 163,954 | 183,822 | 136,773 |
| Income Tax | 35,801 | 2,478 | 17,633 | 34,826 | 24,917 |
| Net Income Continuous | 204,289 | 174,958 | 146,321 | 148,996 | 111,856 |
| Minority Interests | 32 | 168 | 102 | 56 | 29 |
| Net Income | $204,257 | $174,790 | $146,219 | $148,940 | $111,827 |
| EPS Basic Total Ops | 2.39 | 2.05 | 1.71 | 1.75 | 1.31 |
| EPS Basic Continuous Ops | 2.39 | 2.05 | 1.72 | 1.75 | 1.31 |
| EPS Diluted Total Ops | 2.35 | 2.01 | 1.69 | 1.72 | 1.29 |
| EPS Diluted Continuous Ops | 2.35 | 2.01 | 1.69 | 1.72 | 1.29 |
| EBITDA(a) | $272,679 | $209,656 | $196,507 | $216,830 | $167,529 |